Inactivation of nucleolin leads to nucleolar disruption, cell cycle arrest and defects in centrosome duplication

Overview of attention for article published in BMC Molecular and Cell Biology, August 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 178 Dimensions

Readers on

mendeley: 126 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

COMBINATION THERAPY OF NUCANT AND mTOR INHIBITORS FOR TREATING CANCER

Application WO-2022223544-A1

World Intellectual Property Organisation (WIPO)

Compositions comprising multivalent synthetic ligands of surface nucleolin and…

Grant US-9487559-B2

United States of America

Use of multivalent synthetic ligands of surface nucleolin for treating cancer or…

Grant US-9254309-B2

United States of America

NUCLEOLI DISORGANISATION BY KNOCKING DOWN SPECIFIC ALU-REPEAT CONTAINING RNA SEQUENCES

Application WO-2014187856-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.